FILANA THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$95.4 | -$141.4 | -$106.0 | -$80.0 | -$32.9 |
| Net income | -$91.0 | -$24.3 | -$97.2 | -$76.2 | -$32.4 |
| Cash Flow Statement | |||||
| Free cash flow | -$32.8 | -$117.0 | -$82.4 | -$80.2 | -$52.4 |
Shares outstanding 48.3M · Free float 87.9%
Annual filing data through FY ended December 31, 2025; float as of August 21, 2026.